Search
for
Sort by
Research 30 of 117
- The PDE4 inhibitor, apremilast, suppresses experimentally induced alopecia areata in human skin in vivo
- Drug repurposing of cyclin-dependent kinase inhibitors for neutrophilic acute respiratory distress syndrome and psoriasis
- The relative efficacy of monotherapy with Janus kinase inhibitors, dupilumab and apremilast in adults with alopecia areata: Network meta‐analyses of clinical trials
- Phosphodiesterase (PDE) Inhibitors for the Treatment of Inflammatory Skin Conditions
- Systematic review of newer agents for the management of alopecia areata in adults: Janus kinase inhibitors, biologics and phosphodiesterase‐4 inhibitors
- Alopecia areata
- Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Seborrheic Dermatitis Revisited: Pathophysiology, Diagnosis, and Emerging Therapies—A Narrative Review
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Alopecia Areata: A Complex Cytokine Driven Disease
- Dupilumab for alopecia areata treatment: A double‐edged sword?
- Pyroptosis in Alopecia Areata: Synthesizing Emerging Hypotheses and Charting a Path to New Therapies
- Alopesi Tedavisinde Kullanılan İlaç Tedavileri ve Yeni Yaklaşımlar
- A retrospective review of paediatric alopecia areata cases seen in a tertiary institution in Singapore
- Lack of efficacy of apremilast in 9 patients with severe alopecia areata
- Apremilast and tofacitinib exert differential effects in the humanized mouse model of alopecia areata
- Crisaborole as a Potential Treatment for Pediatric Alopecia Areata: A Case Report and Literature Review
- 1113 Targeting anti-inflammatory immunonanocarriers to human and murine neutrophils via Ly6 antigen for psoriasiform dermatitis alleviation
- Apremilast treatment of atopic dermatitis and other chronic eczematous dermatoses
- A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata
- Monovalent antibody-conjugated lipid-polymer nanohybrids for active targeting to desmoglein 3 of keratinocytes to attenuate psoriasiform inflammation
- Exploring the Complexities of Atopic Dermatitis: Pathophysiological Mechanisms and Therapeutic Approaches
- Biologic Therapies and Small-Molecule Inhibitors for Dissecting Cellulitis of the Scalp: A Systematic Review
- Phosphodiesterase inhibitors and prostaglandin analogues in dermatology: A comprehensive review
- The use of phosphodiesterase inhibitors for the treatment of alopecia
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Comment on ‘Androgenetic alopecia is associated with increased scalp hardness’: role of phosphodiesterase inhibitors?
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases